Location: Home
  • search
  • go
  • Relate News
  • 10/15/2019Lonza Tests Water in Chinese CDMO Sector
  • 9/26/2019Thermo Fisher Scientific Expands Clinical Trials Capabilities and Anno...
  • 9/19/2019Covance Unveils New R&D Center in Shanghai
  • 9/17/2019Parexel Expands Phase I Research Capabilities in China
  • 8/21/2019CMAB and Kintor Announce a New Partnership to Develop and Manufacture ...
  • 7/24/2019Outsourcing in China: How Far Can It Go?
  • 5/28/2019Performance of Listed Chinese Pharma CRO/CMDO Companies in 2017/2018
  • 5/21/2019WuXi STA and Dizal Pharma Sign CMC Development and Manufacturing Agree...
  • 5/21/2019WuXi Biologics Signed Letter of Intent for Long-Term Vaccine Manufactu...
  • 5/16/2019WuXi Bio Builds Integrated Manufacturing Center for Innovative Biologi...
  • 5/8/2019Research Point Global and WuXi CDS to Rebrand as WuXi Clinical
  • 5/6/2019WuXi AppTec Acquires Pharmapace to Enhance Biometrics Services for Cli...
  • 4/16/2019I-Mab Bio and WuXi Bio Announce Long-term Strategic Manufacturing Part...
  • 4/16/2019WuXi Bio Set to Lose Contract Manufacturing of First Antibody-based HI...
  • 4/16/2019GenScript Starts Construction of GenScript-Legend Biotech Commercial M...
  • 3/28/2019Chinese Pharma CRO Industry to More Than Triple by 2025
  • 3/27/2019WuXi STA's New Drug Product Manufacturing Facility Passes First Europe...
  • 3/21/2019WuXi STA forms Strategic Partnership with Beta Pharma
  • 3/20/2019China Needs 30 Times Its Outsourcing Capacity to Meet Biologics Demand...
  • 3/6/2019WuXi STA and Ark Biosciences Sign CMC Development and Manufacturing Ag...
  • 2/19/2019WuXi STA and BioLingus Sign Exclusive Technology and Marketing Collabo...
  • 2/16/2019PharmExec - New Roads to China
  • 1/28/2019Advent International Makes Majority Investment in CRO Bioduro
  • 1/18/2019MabPlex's Manufactured mAb Receives IND Approval from the U.S. FDA
  • 1/17/2019Boehringer Ingelheim Expands Biopharma Commercial Manufacturing in Chi...
  • 1/8/2019CANbridge Pharma and WuXi Biologics Expand Rare Disease Therapeutics P...
  • 12/10/2018WuXi AppTec Expands Site in California for Pharmaceutical R&D ...
  • 12/5/2018Changzhou Qianhong Biopharma Expands Facility for Polysaccharides and ...
  • 12/5/2018Wuxi AppTec Says US Hurdles Will Not Dim Acquisition Appetite
  • 11/29/2018WuXi Biologics and ABL Enter Development and Clinical Manufacturing Pa...
  • Page:7/16 Total number of articles:466: [First][<<] [5] [6] [7] [8] [9] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group